What does LAV invest in?
LAV invests most often at Series B and Series C (100% of the rounds on record).
Last cheque observed May 2026; 2 cheques on record.
Growth equityDeploying now
Follow LAV and see its new cheques in your feed. Start following
2 cheques in the last 12 months
Mostly Series B and Series C: 100% of its rounds
Every round we can evidence, newest first2 appearances
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Who backs their funds
The institutions that put money into its funds, which the firm then invests in companies.Source: the pension's own report, latest Jun 2025.
| Fund | Vintage | Committed |
|---|---|---|
| LAV Fund VI | 2021 | $48M |
| LAV Fund VI Opportunities | 2021 | $24M |
| Fund | Vintage | Committed |
|---|---|---|
| LAV VI | 2020 | $30M |
| LAV Opportunities Fund | 2020 | $15M |
LAV invests most often at Series B and Series C (100% of the rounds on record).
2 investments on record, 2 of them in the last 12 months. The most recent was in May 2026.
Its most recent investments on record: Accro Bioscience (Series C, May 2026) and Syneron Bio (Series B, Apr 2026).
The median round it joins is $100M.
Yes: it is actively investing, with 2 investments in the last 12 months.
LAV is a growth equity firm.
From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it